PTEN and cancer: Importantly, through the generation of PTEN knock-in (KI) mouse models, our group and others have demonstrated that two frequent cancer-associated and loss-of-function PTEN mutations (i.e., PTEN G129E and C124S) can dimerize with wild-type PTEN and inhibit its function in a dominant negative manner [96,97,98].